Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD

References

• CelliBRMacNeeWATS/ERS Task ForceStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J200423693294615219010
   PubMed Web of Science ®Google Scholar
• VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• Peces-BarbaGBarberàJAAgustíAGuía clínica SEPAR-ALAT de diagnóstico y tratamiento de la EPOC. [Diagnosis and management of chronic obstructive pulmonary disease: joint guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Latin American Thoracic Society (ALAT)]Arch Bronconeumol2008445271281 Spanish18448019
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJCosíoBIzquierdoJLConsensus document on the overlap phenotype COPD-asthma in COPDArch Bronconeumol2012489331337 Spanish [with English abstract]22341911
   PubMed Web of Science ®Google Scholar
• Platts-MillsTAThe role of immunoglobulin E in allergy and asthmaAm J Respir Crit Care Med20011648 Pt 2S1S511704610
   PubMed Web of Science ®Google Scholar
• HanMKAgustiACalverleyPMChronic obstructive pulmonary disease phenotypes: the future of COPDAm J Respir Crit Care Med2010182559860420522794
   PubMed Web of Science ®Google Scholar
• MiravitllesMCalleMSoler-CataluñaJJClinical phenotypes of COPD: identification, definition and implications for guidelinesArch Bronconeumol20124838698 Spanish [with English abstract]22196477
   PubMed Web of Science ®Google Scholar
• KurashimaKTakakuYOhtaCTakayanagiNYanagisawaTSugitaYCOPD assessment test and severity of airflow limitation in patients with asthma, COPD, and asthma-COPD overlap syndromeInt J Chron Obstruct Pulmon Dis20161147948727019598
   PubMed Web of Science ®Google Scholar
• MiravitllesMSorianoJBAncocheaJCharacterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health statusRespir Med201310771053106023597591
   PubMed Web of Science ®Google Scholar
• HardinMSilvermanEKBarrRGCOPDGene InvestigatorsThe clinical features of the overlap between COPD and asthmaRespir Res20111212721951550
   PubMed Web of Science ®Google Scholar
• MenezesAMBMontes de OcaMPérez-PadillaRPLATINO TeamIncreased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthmaChest2014145229730424114498
   PubMed Web of Science ®Google Scholar
• KobayashiSHanagamaMYamandaSIshidaMYanaiMInflammatory biomarkers in asthma-COPD overlap syndromeInt J Chron Obstruct Pulmon Dis20161121172123 eCollection 201627660429
   PubMed Web of Science ®Google Scholar
• AraújoDPadrãoEMorais-AlmeidaMAsthma-chronic obstructive pulmonary disease overlap syndrome – Literature review and contributions towards a Portuguese consensusRev Port Pneumol (2006)20172329099
   Web of Science ®Google Scholar
• FingletonJTraversJWilliamsMNew Zealand Respiratory Health Survey Study GroupTreatment responsiveness of phenotypes of symptomatic airways obstruction in adultsJ Allergy Clin Immunol2015136360160925746966
   PubMed Web of Science ®Google Scholar
• HurstJRThe rhythm of chronic obstructive pulmonary disease exacerbationsJ Clin Epidemiol201063121285128620800444
   PubMed Web of Science ®Google Scholar
• SantibáñezMGarrastazuRRuiz-NuñezMPredictors of hospi-talized exacerbations and mortality in chronic obstructive pulmonary diseasePLoS One2016116e015872727362765
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJMartínez-GarcíaMARomán SánchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
   PubMed Web of Science ®Google Scholar
• BafadhelMMcKennaSTerrySAcute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkersAm J Respir Crit Care Med2011184666267121680942
   PubMed Web of Science ®Google Scholar
• McDonaldVMHigginsIWoodLGGibsonPGMultidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense?Thorax201368769169423503624
   PubMed Web of Science ®Google Scholar
• NegewoNAMcDonaldVMBainesKJPeripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPDInt J Chron Obstruct Pulmon Dis2016111495150427445469
   PubMed Web of Science ®Google Scholar
• FahyJVLocksleyRMThe airway epithelium as a regulator of Th2 responses in asthmaAm J Respir Crit Care Med2011184439039221844510
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma (GINA)Global strategy for asthma management and preventionNHLBI/WHO workshop report 2002 NHI Publication 02-3659. Available from: http://www.ginasthma.comAccessed July 19, 2017
   Google Scholar
• GartlehnerGHansenRACarsonSSLohrKNEfficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomesAnn Fam Med20064325326216735528
   PubMed Web of Science ®Google Scholar
• JonesPWWillitsLRBurgePSCalverleyPMInhaled Steroids in Obstructive Lung Disease in Europe study investigatorsDisease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbationsEur Respir J2003211687312570111
   PubMed Web of Science ®Google Scholar
• BurgePSCalverleyPMJonesPWSpencerSAndersonJAMaslenTKRandomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ200032072451297130310807619
   PubMed Web of Science ®Google Scholar
• VestboJSørensenTLangePBrixATorrePViskumKLong-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trialLancet199935391671819182310359405
   PubMed Web of Science ®Google Scholar
• KewKMSeniukovichAInhaled steroids and risk of pneumonia for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20143CD010115
   PubMed Web of Science ®Google Scholar
• VestboJVogelmeierCSmallMHigginsVUnderstanding the GOLD 2011 Strategy as applied to a real-world COPD populationRespir Med2014108572973624675239
   PubMed Web of Science ®Google Scholar
• PriceDWestDBrusselleGManagement of COPD in the UK primary-care setting: an analysis of real-life prescribing patternsInt J Chron Obstruct Pulmon Dis2014988990425210450
   PubMed Web of Science ®Google Scholar
• MiravitllesMSoler-CataluñaJJCalleMSorianoJBTreatment of COPD by clinical phenotypes: putting old evidence into clinical practiceEur Respir J20134161252125623060631
   PubMed Web of Science ®Google Scholar
• RennardSICalverleyPMGoehringUMBredenbrökerDMartinezFJReduction of exacerbations by the PDE4 inhibitor roflumilast – the importance of defining different subsets of patients with COPDRespir Res2011121821272339
   PubMed Web of Science ®Google Scholar
• SivaRGreenRHBrightlingCEEosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trialEur Respir J200729590691317301099
   PubMed Web of Science ®Google Scholar
• PascoeSLocantoreNDransfieldMTBarnesNCPavordIDBlood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trialsLancet Respir Med20153643544225878028
   PubMed Web of Science ®Google Scholar
• SiddiquiSHGuasconiAVestboJBlood eosinophils: a biomarker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2015192452352526051430
   PubMed Web of Science ®Google Scholar
• DransfieldMTBourbeauJJonesPWOnce-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trialsLancet Respir Med20131321022324429127
   PubMed Web of Science ®Google Scholar
• LeeSYParkHYKimEKCombination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndromeInt J Chron Obstruct Pulmon Dis20161127972803 eCollection 201627877033
   PubMed Web of Science ®Google Scholar
• RocheNChapmanKRVogelmeierCFReply to correspondence letter regarding “Blood eosinophils and response to maintenance COPD treatment: data from the FLAME trial”Am J Respir Crit Care Med Epub2017626
   Web of Science ®Google Scholar
• ChengSLLinCHEffectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic countsInt J Chron Obstruct Pulmon Dis2016112341234827703344
   PubMed Web of Science ®Google Scholar
• LeighRPizzichiniMMMorrisMMMaltaisFHargreaveFEPizzichiniEStable COPD: predicting benefit from high-dose inhaled corticosteroid treatmentEur Respir J200627596497116446316
   PubMed Web of Science ®Google Scholar
• BrightlingCEMonteiroWWardRSputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trialLancet200035692401480148511081531
   PubMed Web of Science ®Google Scholar